Captopril-associated neutropenia. who is at risk?
Cooper, R.A.
Archives of Internal Medicine 143(4): 659-660
1983
ISSN/ISBN: 0003-9926 PMID: 6340620 Document Number: 217611
Document emailed within 1 workday
Related Documents
Carter, L.W. 1993: Influences of nutrition and stress on people at risk for neutropenia: nursing implications Oncology Nursing Forum 20(8): 1241-1250Mouzinho, A.; Rosenfeld, C.R.; Sanchez, P.J.; Risser, R. 1992: Effect of maternal hypertension on neonatal neutropenia and risk of nosocomial infection Pediatrics 90(3): 430-435
Chayakulkeeree, M.; Thamlikitkul, V. 2003: Risk index for predicting complications and prognosis in Thai patients with neutropenia and fever Journal of the Medical Association of Thailand 86(3): 212-223
Mahapatra, D.; Mahapatra, R.K.; Yaden, S.; Hunter, K.W. 1986: Acute titration and chronic follow-up with captopril in hypertension. a one-year safety profile on combination therapy with captopril and a diuretic Angiology 37(12 Part 1): 865-879
Pereira, C.A.P.; Petrilli, A.S.ér.; Carlesse, F.A.; Luisi, F.áv.A.V.; da Silva, K.át.V.ôn.T.B.; de Martino Lee, M.L.úc. 2009: Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison Journal of Microbiology Immunology and Infection 42(2): 141-147
Miyazaki, N.; Shionoiri, H.; Uneda, S.; Yasuda, G.; Gotoh, E.; Fujishima, S.; Kaneko, Y.; Kawahara, Y.; Yamazaki, Y. 1982: Blood concentration and urinary excretion of captopril (SQ 14,255), angiotensin converting enzyme activity and R-A-A system after administration of captopril--in patients with chronic renal failure compared with essential hypertension Nihon Jinzo Gakkai Shi 24(4): 421-428
1998: Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group Bmj 317(7160): 713-720
Hanada, N.; Tanaka, S.; Takahata, T.; Sato, A. 2014: Use of granulocyte-colony stimulating factor(G-CSF)in patients with cancer at high risk of febrile neutropenia on the basis of high age and complications, recommendations for patients receiving radiotherapy, and adverse events because of G-CSF Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(6): 702-706
Metelitsa, V.I.; Ostrovskaia, T.P.; Duda, S.G.; Filatova, N.P.; Vygodin, V.A. 1995: The long-term monotherapy with preparations from the 4 basic groups of antihypertensive agents of patients with mild and moderate arterial hypertension. the Multicenter Captopril and the Quality of Life Study. the working group of the Multicenter Captopril and the Quality of Life Study Terapevticheskii Arkhiv 67(6): 15-20
Al-Ankoodi, Y.; Rawther, S. 2004: Neutropenia Saudi Medical Journal 25(10): 1507-1508
Forgan-Smith, J.; Leslie, P. 1985: Neutropenia and mianserin Medical Journal of Australia 143(9): 398
Taniuchi, S. 2005: Autoimmune neutropenia Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 5): 466-470
Trowbridge, A.A. 1977: Neutropenia: when and when not to treat Postgraduate Medicine 61(4): 208-215
Al-Namlah, R.A.; Al-Qahtani, M.M.; Daghash, H.F. 2009: Neutropenia among psychiatric in-patients Neurosciences 14(3): 260-262
Bulucea, D.; Iofciulescu, A. 1978: Blood neutropenia in children Revista de Pediatrie Obstetrica Si Ginecologie. Pediatria 27(3): 217-224
Burgaleta, C.; Parras, F.; Hermida, J.M. 1989: Neutropenia secondary to cefotaxime use Enfermedades Infecciosas y Microbiologia Clinica 7(7): 364-367
Cooksley, T.; Holland, M. 2012: The febrile patient with neutropenia Acute Medicine 11(4): 246-250
Kølbæk, M.D.; Windelborg, B.; Nielsen, K.R.é 2011: Autoimmune neutropenia in children Ugeskrift for Laeger 173(46): 2957-2959
Salazar Cabrera, A.N.; Berrón Pérez, R.; Ortega Martell, J.A.; Onuma Takane, E. 1996: Asthma and cyclic neutropenia Allergologia et Immunopathologia 24(1): 25-28
Dourdine, D.; Cadranel, S.; Rodesch, P.; Cremer, N.; Frühling, J. 1975: Pancreatic insufficiency and neutropenia Pediatrie 30(5): 543-544